ATS 2018
Efficacy, Safety of Dupilumab in Corticosteroid-Dependent Severe Asthma
Subcutaneous dupilumab significantly reduced the use of oral corticosteroids in patients with corticosteroid-dependent severe asthma.
Your search for oral corticosteroids returned 12 results
ATS 2018
Lung Function in Severe Asthma Improved With Benralizumab
Peak expiratory flow increases were greater with benralizumab than placebo in patients with severe eosinophilic asthma.
ACAAI 2018
Increased Medication Burden for Patients With Both Asthma and Allergies
Patients with both asthma and allergies had a significant increase in the number of prescriptions dispensed for controller medications.
AES 2017
Effectiveness of Infantile Spasm Treatments Compared
Results found that infants with an unknown epilepsy etiology, a normal MRI, an EEG displaying hypsarrhythmia, or those already receiving an AED were more likely to be administered ACTH.
CHEST 2018
Inhaled Corticosteroid Therapy Refill Disruption Leads to Exacerbations
Disrupting regular combination inhaled corticosteroid therapy refills increased hospitalizations and exacerbations.
AAAAI 2017
Omalizumab Associated with Reduced Allergic Asthma Exacerbations, Hospitalizations
Omalizumab therapy was associated with reduced exacerbation and hospitalization rates in US clinics, according to findings from the prospective multicenter observational registry PROSPERO study
AAAAI/WAO 2018
Oral Glucocorticoid Use and Morbidities Examined in Pediatrics
Children with asthma who experience chronic oral glucocorticoid exposure may have significant morbidities, including adrenal suppression, recurrent pneumonia, and behavioral problems.
ACR/ARHP Annual Meeting 2015
Ustekinumab Beneficial in Patients With Psoriatic Arthritis with Spondylitis and Peripheral Joint Involvement
Ustekinumab (UST) benefits patients with psoriatic arthritis (PsA) with spondylitis and peripheral joint involvement, according to an post-hoc analysis of results from the PSUMMIT 1 & 2 phase 3 double-blind, placebo-controlled clinical trials, reported at the 2015 ACR/ARHP Annual Meeting.
AAAAI/WAO 2018
Reslizumab Efficacy Examined in Severe Eosinophilic Asthma
Reslizumab reduced the risk for exacerbations and improved lung function when compared to placebo, in patients with severe eosinophilic asthma.
ACR 2019, News
Guselkumab Demonstrates Efficacy in Biologic-Naive or TNFi-Treated Patients With Psoriatic Arthritis
Researchers evaluated the efficacy and safety of guselkumab in patients with active psoriatic arthritis who were biologic-naive or treated with prior tumor necrosis factor inhibitors.
